Skip to content
10-Q

Quarterly Report

ROCHESTER MEDICAL CORPORATION

0001104659-13-009312

← back to feed
Filed
Feb 11, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Jan 31, 2013 12.21M sh
Shares Diluted Q1 2013 · Dec 31, 2012 12.4M sh
Shares Diluted Q1 2013 · Dec 31, 2011 12.14M sh
Capex Q1 2013 · Dec 31, 2012 $784.11K
Capex Q1 2013 · Dec 31, 2011 $585.13K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $16.31M
Cash And Equivalents Q1 2013 · Sep 30, 2012 $13.92M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $8.34M
Cash And Equivalents Q1 2013 · Sep 30, 2011 $8.72M
Stockholders Equity Q1 2013 · Dec 31, 2012 $70.45M
Stockholders Equity Q1 2013 · Sep 30, 2012 $68.3M
Current Liabilities Q1 2013 · Dec 31, 2012 $5.27M
Current Liabilities Q1 2013 · Sep 30, 2012 $6.5M
Current Assets Q1 2013 · Dec 31, 2012 $45.04M
Current Assets Q1 2013 · Sep 30, 2012 $44.61M
Total Assets Q1 2013 · Dec 31, 2012 $76.89M
Total Assets Q1 2013 · Sep 30, 2012 $75.93M
Eps Diluted Q1 2013 · Dec 31, 2012 $0.08
Eps Diluted Q1 2013 · Dec 31, 2011 −$0.01
Eps Basic Q1 2013 · Dec 31, 2012 $0.08
Eps Basic Q1 2013 · Dec 31, 2011 −$0.01
Sga Expense Q1 2013 · Dec 31, 2012 $2.21M
Sga Expense Q1 2013 · Dec 31, 2011 $2.11M
Rd Expense Q1 2013 · Dec 31, 2012 $339.16K
Rd Expense Q1 2013 · Dec 31, 2011 $376.27K
Operating Income Q1 2013 · Dec 31, 2012 $1.38M
Operating Income Q1 2013 · Dec 31, 2011 −$20.73K
Gross Profit Q1 2013 · Dec 31, 2012 $8.47M
Gross Profit restated Q1 2013 · Dec 31, 2011 $7.11M
Cost Of Revenue Q1 2013 · Dec 31, 2012 $8.78M
Cost Of Revenue restated Q1 2013 · Dec 31, 2011 $6.86M
Stock Repurchased Q1 2013 · Dec 31, 2011 $1.09M